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Abstract
Diagnostic radiology represents the largest man-made contribution to population 
radiation doses in Europe. to be able to keep the diagnostic benefit versus 
radiation risk ratio as high as possible, it is important to understand the 
quantitative relationship between the patient radiation dose and the various 
factors which affect the dose, such as the scan parameters, scan mode, and patient 
size. Paediatric patients have a higher probability for late radiation effects, since 
longer life expectancy is combined with the higher radiation sensitivity of the 
developing organs. the experience with particular paediatric examinations may 
be very limited and paediatric acquisition protocols may not be optimised.
the purpose of this thesis was to enhance and compare different dosimetric 
protocols, to promote the establishment of the paediatric diagnostic reference 
levels (DRLs), and to provide new data on patient doses for optimisation purposes 
in computed tomography (with new applications for dental imaging) and in 
paediatric radiography.
Large variations in radiation exposure in paediatric skull, sinus, chest, pelvic and 
abdominal radiography examinations were discovered in patient dose surveys. 
there were variations between different hospitals and examination rooms, 
between different sized patients, and between imaging techniques; emphasising 
the need for harmonisation of the examination protocols. 
For computed tomography, a correction coefficient, which takes individual patient 
size into account in patient dosimetry, was created. the presented patient size 
correction method can be used for both adult and paediatric purposes. Dental 
cone beam ct scanners provided adequate image quality for dentomaxillofacial 
examinations while delivering considerably smaller effective doses to patient 
compared to the multi slice ct. However, large dose differences between cone 
beam ct scanners were not explained by differences in image quality, which 
indicated the lack of optimisation.
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For paediatric radiography, a graphical method was created for setting the 
diagnostic reference levels in chest examinations, and the DRLs were given 
as a function of patient projection thickness. Paediatric DRLs were also 
given for sinus radiography. the detailed information about the patient data, 
exposure parameters and procedures provided tools for reducing the patient 
doses in paediatric radiography. the mean tissue doses presented for paediatric 
radiography enabled future risk assessments to be done. the calculated effective 
doses can be used for comparing different diagnostic procedures, as well as for 
comparing the use of similar technologies and procedures in different hospitals 
and countries.
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KILJUNEN Timo. Potilasannokset TT:ssa, hampaiston kartiokeila TT:ssa ja 
projektiokuvauksessa Suomessa painottuen lapsipotilaisiin. STUK-A232. Helsinki 
2008, 62 s. + liitteet 59 s.
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Tiivistelmä
Diagnostisen röntgensäteilyn osuus ihmisen aiheuttamasta väestön 
keskimääräisestä säteilyannoksesta on kaikkein suurin. Jotta diagnostisen 
hyödyn ja säteilyhaitan välinen suhde voidaan pitää mahdollisimman suurena, 
on tärkeää ymmärtää kvantitatiivisesti potilaan säteilyannoksen ja siihen 
vaikuttavien tekijöiden, kuten kuvausarvojen, kuvausmenetelmien ja potilaiden 
kokojen välinen suhde. Lapsipotilailla on aikuisia suurempi riski säteilyn 
myöhäisiin haittavaikutuksiin, mikä on seurausta pitkästä odotettavissa 
olevasta eliniästä sekä kehittyvien elinten korkeasta säteilyherkkyydestä. 
Henkilökunnan kokemus tietyissä lasten tutkimuksissa voi olla rajallinen eikä 
lasten kuvausmenetelmiä välttämättä ole optimoitu.
työn tarkoituksena oli kehittää ja vertailla eri annosmittausmenetelmiä 
tietokonetomografiatutkimuksissa (tt) ja lasten natiiviröntgentutkimuksissa, 
edistää lasten vertailutasojen käyttöönottoa sekä tuottaa uutta potilasannostietoa 
röntgentutkimusten optimointia varten.
Potilasannoskartoituksissa todettiin suuria vaihteluita kuvaustekniikoissa 
eri sairaaloiden, tutkimushuoneiden ja eri kokoisten potilaiden välillä. 
tutkimustekniikoiden vaihtelusta aiheutuneet erot potilasannoksissa 
osoittivat tarvetta kuvausmenetelmien optimoinnille sekä kansallisella, että 
kansainvälisellä tasolla.
tietokonetomografiatutkimuksia varten kehitettiin korjauskerroin, joka ottaa 
potilaan koon huomioon aikuisten ja lasten potilasannoksia määritettäessä. 
tietokonetomografiatutkimuksissa lapset, naiset ja pienikokoiset potilaat 
absorboivat säteilyä suhteellisesti isokokoisia potilaita voimakkaammin. 
Hampaiston kuvantamisessa käytettävien rajoitetun kartiokeilan tt-laitteiden 
kuvanlaatu todettiin riittäväksi potilasannosten ollessa oleellisesti pienempiä 
kuin monileike-tt-laitteilla. Eri kartiokeila-tt-laitteiden potilasannoksissa 
oli kuitenkin suuria eroja kuvanlaadusta riippumatta, mikä osoitti tarvetta 
kuvaustekniikoiden jatkokehitykselle.
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Lasten keuhkokuvauksia varten annettiin graafiset vertailutasot, joiden avulla 
sairaalat voivat suoraan verrata eri kokoisten potilaiden säteilyannoksia 
vertailutasoon. Vertailutasot annettiin myös lasten nenän sivuontelokuvauksia 
varten. Yksityiskohtaiset tiedot kerätystä aineistosta, kuvausarvoista ja 
-menetelmistä antoivat työkalut potilasannosten vähentämiseksi lasten 
natiiviröntgentutkimuksissa. Kudoksiin absorboituvien annosten määrittäminen 
mahdollistaa jatkossa potilaskohtaiset  riskiarvioinnit. Määritettyjä efektiivisiä 
annoksia voidaan käyttää diagnostisten menetelmien ja kuvaustekniikoiden 
vertailuun eri sairaaloiden ja valtioiden välillä.
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1 Introduction
the number and range of X-ray facilities and X-ray equipment is increasing 
rapidly and diagnostic radiology represents the largest man-made contribution 
to population doses in Europe (Mettler et al. 2008, colgan et al. 2007, Muikku 
et al. 2007, watson et al. 2005, Ec 1997, Schibilla 1991). this observation 
applies to both developing and developed countries alike (UNScEAR 2000). 
the European and national legislation concerning radiation protection states 
that the data concerning the risk caused to the patient by the use of radiation 
should be available, and special attention should be paid to paediatric imaging, 
fluoroscopy and computed tomography (Ec 1997). In principle, the standard dose 
quantities registered from X-ray examinations should provide sufficient data for 
such radiation risk estimate. Patient dosimetry is regarded as an integral part 
of a quality assurance programme (Amis et al. 2007, IAEA 2007, IcRU 2005, 
StUK 2006a, AAPM 2002). the objective of dosimetry in radiological imaging 
is the quantification of radiation exposure within an approach to optimise the 
image quality to absorbed dose ratio. the objective of optimisation is to decrease 
the total patient dose in radiology and to reduce stochastic detriments, or cancer 
incidence, for the population without compromising diagnosis. Dosimetry also 
provides the means to avoid excessive doses that could imply a significant risk 
of induction of deterministic effects, or effects that cause straight detriments, 
such as skin burns. the dosimetric quantities and dosimetric protocols relevant 
in radiological imaging are those most closely related to the risks for the patient 
(IAEA 2007, IcRU 2005). Optimisation studies involve the assessment of the 
detriment associated with the radiation exposure, but also an estimation of the 
benefit the patient derives from the procedure by comparing the patient dose and 
corresponding image quality. the optimisation task is to maximise the benefit 
versus risk ratio for the diagnostic radiology procedure. the benefit risk ratio 
may be maximised by improving the benefit (such as an improved diagnosis) 
and by reducing the radiation risk by lowering the patient doses. Determination 
of the radiation exposure may be performed prospectively before the patient 
is scheduled to have an examination, measured during the examinations, or 
retrospectively after the examination has been performed, assuming that the 
dosimetric methods are well-known.
the guidance levels (or reference doses) for radiological imaging have been 
recommended by international organisations as a means of patient dose reduction 
(IAEA 1996, IcRP 1996a, Ec 1996, cEc 1991). the Medical Exposure Directive 
(MED), 97/43/Euratom, of the European commission (Ec) (Ec 1997) requires 
the member states to promote the establishment and use of diagnostic reference 
levels (DRL) for diagnostic examinations in radiology and nuclear medicine. 
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the Ministry of Social Affairs and Health takes into account the requirements 
of the MED in Finland (Ministry of Social Affairs and Health 2000). the DRLs 
are regarded as a tool for dose minimisation, and are based on the results of 
patient dose surveys. Diagnostic reference levels are expected not to be exceeded 
for standard procedures when good and normal practice regarding diagnostic 
and technical performance is applied (Ec 1997). By using DRLs, it is possible 
to find those hospitals where radiation doses are exceptionally high and where 
practices may need to be improved. Various dosimetry quantities have been 
specified for DRL purposes. these include an entrance surface dose, dose-area 
product, computed tomography dose index, dose-length product and imaging 
time in fluoroscopy. Regular patient dose surveys in hospitals are integral to 
this process of dose minimisation. It is envisaged that patient dosimetry surveys 
will be performed to identify facilities where doses are in the upper quartile of 
the patient dose distribution. An audit of practices in the facility follows, with 
the intention of identifying dose reduction measures and improvements in 
techniques.
computed tomography (ct) has grown into a major contributor to radiation 
dose obtained by patients in radiological studies. currently, the ct studies may 
cover up to 17% of the procedures while already accounting for 60-75% of the 
diagnostic radiation dose received by the patients (Paterson and Frush 2007, 
Børretzen et al. 2007). From the early 1990s to the early 2000s, ct covered 
about 4% of procedures and 40% of the radiation dose (Shrimpton et al. 1991, 
Shrimpton and Edyvean 1998, Nagel 2002, Hart and wall 2004, Karppinen and 
Järvinen 2006). thus, the multi-slice ct (MSct) scanners and their applications 
have contributed to the significant increase of dose in one particular modality. 
In Finland, the number of ct scanners was 15 per million inhabitants and ca. 
50 000 ct examinations were done per million inhabitants per year (Rantanen 
2007, tenkanen-Rautakoski 2006). Both numbers were close to the mean value of 
developed countries, with the highest numbers in Japan and United States and 
the lowest in United Kingdom (Hall and Brenner 2008, UNScEAR 2000). the 
increased utilization of ct (Figure 1) can be primarily attributed to two factors. 
MSct and helical scanning are increasingly used in diagnostic imaging because 
of their efficiency as a diagnostic tool, providing simultaneously speed, high 
resolution and large coverage for diagnostic evaluation. Also, new applications 
of ct have expanded the role of ct into new types of clinical diagnoses, such as 
peripheral and cardiac angiography; virtual endoscopy, including bronchoscopy 
and colonoscopy; and multiplanar and volume reformats from isotropic data sets. 
15
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these are all now being performed using ct (Mahesh and cody 2007, Einstein 
et al. 2007, Ouwendijk et al. 2005, Heyer et al. 2007, Kim et al. 2007, Elena 
2008). Even though the benefits derived from ct examinations are considerable, 
the large number of ct scans performed each year, and the magnitude of the 
radiation doses from these examinations, has drawn attention to the potential 
risks from exposure to ionising radiation (goldman 2008, Boland et al. 2008, 
golding 2008, Brenner et al. 2001, Faulkner and Moores 1987). For example, 
the Alliance for radiation safety in paediatric imaging raises awareness in the 
imaging community on the need to adjust radiation dose in ct when children 
are imaged (www.imagegently.com). Despite similar ct scan parameters, both 
the image quality and the radiation dose delivered during ct procedures depend 
upon the patient size (Lee et al. 2008, Zatelli et al.2008, McNitt-gray 2002, Frush 
2002, Nickoloff 2002, Huda et al. 2001, ware et al. 1999). the optimisation of ct 
exams requires a selection of scan factors that minimises the radiation dose to 
patients without having a significant impact upon the diagnostic accuracy of the 
examinations. thus, it is important to understand the quantitative relationship 
between the patient radiation dose and the various factors which affect the dose. 
these include, for example, the scan parameters, scan mode, and patient size 
(Slovis 2002, Paterson et al. 2001, Donnelly et al. 2001).
Limited cone beam computed tomography (cBct, µ-ct) scanners have 
been developed for dental and maxillo-facial imaging (Araki et al. 2004, Arai et 
al. 1999, Mozzo et al. 1998). Dental cBct scanners use a fairly narrow cone-
shaped X-ray beam instead of a wider fan or cone beam, which results in a scan 
range with a more restricted field of view (FOV) in the axial dimension than in 
traditional ct. the advantages of cBct compared with MSct are lower costs, 
smaller size of the scanner and lower radiation dose (Hashimoto et al. 2003). 
However, the image quality and radiation doses of cBct scanners have not been 
thoroughly evaluated and compared to MSct using the same method in both 
modalities. thus the evaluation of the potential benefits and radiation burden 
that a specific examination causes to the patient has been difficult. the increasing 
use of cBct examinations requires critical evaluation of these aspects.
16
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Figure 1. Estimated number of CT scans performed annually in United States (Brenner 
and Hall 2007).
Paediatric patients are a specific group regarding radiation protection in 
radiology because of the elevated risk for radiation detriments (UNScEAR 
2000). Paediatric patients have a higher probability for late radiation effects and 
they are assumed to be 2–3 times more radiation sensitive compared to adults, 
since their longer life expectancy time is combined with the higher radiation 
sensitivity of the developing organs, (UNScEAR 2000, Ec 1998, IcRP 1991). 
Also, there is evidence that low doses of ionising radiation to the brain in infancy 
influence cognitive abilities in adulthood at radiation doses equivalent to those 
of computed tomography (Hall et al. 2004, Huda et al. 2001). In Finland, about 
4.1 million medical X-ray examinations are performed per year, of which close 
to 9% are for paediatric patients (Hakanen et al. 2003, Servomaa et al. 1997). 
the number of acquisitions and the dose per image should be reduced as much 
as possible. to be able to keep doses as low as reasonably achievable (ALARA 
principle), a fundamental knowledge of the factors concerning patient doses 
is needed. In study III, four facts that lead to relatively high patient doses in 
paediatric radiology were summarized:
•	 If	a	paediatric	examination	is	performed	once,	the	examination	is	most	likely	
to be repeated. the mean number of repeated examinations for a neonate is 
8–9 with maximum repetition number close to one hundred (Smans et al. 
2008, Donadieu et al. 2006, Kettunen 2004). cumulative organ doses and the 
effective dose per patient are usually neither known nor registered.
17
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•	 The	number	 of	 paediatric	 patients	 in	 a	 radiology	department	 is	usually	
small compared to adults. As a consequence, the experience with particular 
paediatric examinations may be very limited and paediatric acquisition 
protocols may not be optimised.
•	 Reference	 values	 for	 dose	 quantities	 of	 paediatric	 examinations	 can	 be	
retrieved from only a few publications (UNScEAR 2000, Hart et al. 2000a, 
Ec 1996). Notwithstanding the increased interest and legal requirements 
in the Ec (Ministry of Social Affairs and Health 2000, Ec 1997) for patient 
dosimetry and especially for paediatric patients, large multi-centre studies 
have not been performed in the recent past.
•	 Methods	to	limit	the	dose,	such	as	the	use	of	gonad	protection	or	collimation,	
are not harmonised over Europe.
18
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2 Patient dose and cancer risk
2.1 Linear no-threshold model
the basis for low dose radiation protection has been based on the linear 
no-threshold (LNt) theory of radiation carcinogenesis (IcRP 2008). According to 
the theory, a single radiation particle can initiate a cancer by hitting a single DNA 
molecule in the nucleus of a single human cell. the number of radiation particles 
is proportional to the dose, which is hence proportional to cancer initiation. thus, 
when the number of damaged cells is decreased by a factor of 10, the expected 
biological response decreases by the same factor of 10; i.e., the response decreases 
linearly with decreasing dose. (Brenner et al. 2003, cohen 2002)
Quantitative assessment of radiation carcinogenesis risks (or stochastic 
detriments) at low doses is based on the life span study (LSS) cohort of Hiroshima 
and Nagasaki atomic bomb survivors (Preston et al. 2007). the latest LSS 
data comprised of 17 448 primary cancers diagnosed from 1958 through 1998 
among 105 427 cohort members. the data presented by Preston et al. were 
consistent with a linear dose-response at the low dose range. Linear dose-
response extrapolated to low doses is presented in figure 2 (Pierce and Preston 
2000). Another conclusion from the atomic bomb data is the fact that children 
are much more sensitive to radiation initiated carcinogenetic effects than older 
population. children have more time to express a cancer than adults and children 
are inherently more sensitive to radiation because they have more dividing cells 
promoting the DNA mutagenesis (Brenner 2002). these facts give the shape 
for the sharply descending dose response function in figure 3, presented by the 
committee on the biological effects of ionising radiations (BEIR 2006), which is 
based on the atomic bomb data.
19
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Figure 2. Relative cancer incidence as a function of dose (Pierce and Preston 2000). The 
dotted curves represent ± 1 standard error for the smoothed curve. The straight line 
is fitted over the whole dose range of 0–2 Sv (inset) standing for the LNT theory. The 
main figure is an expanded version of the low-dose region up to 0.5 Sv. Because of 
an apparent distinction between distal and proximal zero-dose cancer rates, the unity 
baseline corresponds to zero-dose survivors within 3 km of the bombs. The dashed 
line represents the alternative baseline if the distal survivors are not omitted (Hall and 
Brenner 2008).
the dependence between cancer incidence and dose has not been proved with 
statistical significance when the dose is lower than 6–40 mSv. For the atomic bomb 
survivors the estimated excess relative risk (ERR) was statistically significant 
(p = 0.025) in dose category of 5–125 mSv, with 34 mSv mean dose for the 
increase in solid cancer related mortality (Brenner et al. 2003). cardis et al. 
(1995) and Muirhead et al. (1999) published results comprising of US, UK and 
canadian nuclear workers with mean dose values of 30 and 40 mSv. the risk 
for leukaemia was significantly associated with cumulative external radiation 
dose (p = 0.05), but no excessive radiation risk was observed for other cancers. 
However, a larger 15 nation study (400 000 nuclear workers) was initiated and 
the results indicated a statistically significant ERR estimate of 0.97 (95% cI 0.14 
to 1.97) per Sv, with a mean dose of 20 mSv (cardis et al. 2005, 2007). the first 
analysis of solid cancer incidence in the techa River cohort showed an ERR of 
1.0 gy-1 (p = 0.004, 95% cI 0.3; 1.9, mean dose 30 mgy) without any significant 
non-linearity in the dose response (Krestinina 2007). Also, statistically significant 
excess cancer incidence and mortality risks for solid cancers were found in the 
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canadian studies, where the mean dose was 6.5 mSv (Ashmore et al. 1998, Sont 
et al. 2001).
Radiation risks are reviewed regularly by both national and international 
organisations (i.e. IcRP 2008, BEIR 2006, NcRP 2001, UNScEAR 2000, NRPB 
1995). the current consensus of these bodies is that for radiation protection 
purposes, the risk model in which the risk of radiation-induced cancer and 
hereditary disease is assumed to increase with increasing radiation dose without 
threshold is considered the most appropriate. Any increment of exposure above 
natural background levels will produce a linear increment of risk (wall et al. 
2006).
Figure 3. Estimated lifetime risk from a single small dose of radiation as a function of age 
at exposure (BEIR 2006). There is a strong decrease in radiation sensitivity with age. In 
addition, females are more sensitive compared to men. The higher risk for the younger 
age groups is not expressed until late in life (Preston et al. 2007, BEIR 2006).
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3 Purpose and structure of the thesis
the purpose of this thesis was to enhance and compare different dosimetric 
protocols, to promote the establishment of the paediatric DRLs, and to provide 
new data on patient doses for optimisation purposes in diagnostic radiology. the 
thesis was focused on those radiological procedures, where the risks for radiation 
detriment are the largest. Potentially the most detrimental imaging modality, 
ct (with new applications for dental imaging), and the most risky patient group, 
paediatric patients, were included in the thesis. As fluoroscopy imaging is a 
complex technique and the evaluation of the protocols would require a thesis of 
its own, it was excluded from the thesis. the thesis was based on five original 
articles referred to in the text by their Roman numerals. the specific aims of 
the thesis work were:
•	 to	present	an	individual	method	doing	patient	dose	calculations	in	computed	
tomography, accounting for patient size for adult and paediatric patients in 
physical dose estimates and effective dose determinations (Study I)
•	 to	compare	the	above	method	with	standard	dose	quantities	based	on	standard	
geometry (Study I)
•	 to	determine	the	tissue	and	effective	doses	of	dental	cone	beam	CT	scanners	
in comparison with multi slice ct scanners (Study IV)
•	 to	evaluate	the	influence	of	the	revised	tissue	weighting	factors	in	cranial	
X-ray examinations (Study IV)
•	 to	present	a	method	that	takes	into	account	patient	size	when	setting	the	
paediatric diagnostic reference levels for chest X-ray examinations (Study 
II)
•	 to	present	preliminary	European	DRLs	for	paediatric	X-ray	examinations	
(Study III)
•	 to	provide	 information	 on	 the	paediatric	 examination	protocols,	 entrance	
surface doses (ESD) and dose area products (DAP) for different aged children 
(Studies II, III, V)
•	 to	 determine	 organ	 doses	 and	 effective	 doses	 in	 paediatric	 projection	
radiography (Study V)
•	 to	use	patient	dose	data	 for	 optimisation	of	 skull,	 paranasal	 sinus,	 chest,	
abdominal, and pelvic examinations (Study V).
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•	 Article	I:
Kortesniemi M, Kiljunen T, Kangasmäki A:
Radiation exposure in body computed tomography examinations of trauma 
patients.
Phys. Med. Biol. 2006; 51: 3269–3282.
the ct examination data from abdominal and thoracic scan series were collected 
from 36 trauma patients. the ctDIvol, DLPw and effective dose were determined, 
and the influence of patient size was applied as a correction factor to the 
calculated doses. the patient size was estimated from the patient weight by 
introducing a new correction factor for standard dose quantities. the correction 
was produced by analyzing the cross sectional areas and ct numbers from the 
axial images of abdominal and thoracic scan regions. 
•	 Article	II:
Kiljunen T, Järvinen H, Savolainen S:
Diagnostic reference levels for thorax X-ray examinations of paediatric 
patients.
Br. J. Radiol. 2007; 80: 452–459.
the paediatric dose data from earlier Finnish surveys were collected and patient 
dose measurements were executed in two regional hospitals. Different methods 
for setting the paediatric DRLs were considered and a new method was introduced 
for chest examinations. 
•	 Article	III:	
Smans K, Vano E, Sanchez R, Schultz Fw, Zoetelief J, Kiljunen T, Maccia c, 
Järvinen H, Bly R, Kosunen A, Faulkner K, Bosmans H:
Results of a European survey on patient doses in paediatric radiology.
Rad. Prot. Dosim. 2008; 129(1-3): 204–10.
A questionnaire was sent to the SENtINEL members asking for all available 
paediatric dose data, and procedure data for chest radiography of newborns. 
the data were gathered from 14 project partners from 13 European countries 
and preliminary DRLs were suggested to update the earlier values by European 
commission.
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•	 Article	IV:
Suomalainen A, Kiljunen T, Käser Y, Peltola J, Kortesniemi M:
Dosimetry and image quality of four dental cBct scanners compared with 
MSct scanners.
Dentomaxillofacial Radiology (in press).
tissue doses in dental cBct examinations were measured using a tissue-
equivalent anthropomorphic RANDO head phantom with thermoluminescence 
dosimeters (tLD). An RSVP head phantom with a specially designed cylindrical 
insert was used for comparison of image quality and absorbed dose. Image quality 
was evaluated in the form of contrast-to-noise ratio (cNR) and modulation 
transfer function (MtF).
•	 Article	V:
Kiljunen T, tietäväinen A, Parviainen t, Viitala A, Kortesniemi M:
Organ and effective doses in pediatric radiography – Patient dose survey in 
Finland.
 Acta Radiologica (in press).
Paediatric examination data including patient information, examination 
parameters and specifications were registered in 24 Finnish hospitals. ESD and 
DAP were calculated retrospectively and/or DAP meters were used. Organ and 
effective doses were determined using a Monte carlo programme PcXMc.
the author’s contribution to the studies was: literature review and planning 
the method for the patient size corrections, performing the patient size analysis 
and producing the corrected dose quantities, and co-writing the article (I), 
constructing the study and performing the literature review; collecting, analysing 
and reporting the data, and writing the  article (II), initiating the project together 
with SENtINEL participants, analysing and producing the Finnish paediatric 
dose data, co-analysing the European dose data and co-writing the  article (III), 
planning the patient dose study, determining the tissue and effective doses, 
co-measuring the image quality and co-writing the  article (IV), planning and 
executing the dose collection, analysing the data, performing the ESD and DAP 
calculations and most of the effective dose determinations, and writing the 
article (V). In addition, the author was drafting or revising and making the final 
approval of the versions of all the papers published as stated in the Vancouver 
convention. these study results have not been used in other Ph.D. theses.
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4 Materials and methods
4.1 Patient dose quantities
In radiological imaging, several quantities are used to quantify the magnitude of 
the exposure of the patient to ionising radiation (such as entrance surface dose, 
entrance surface air kerma, entrance skin dose, etc.). there is some ambiguity 
in their names and application in radiological procedures. the medical and 
radiobiological community currently relates the biological effects to the absorbed 
dose, which for medical X-rays and most common tissue equivalent materials 
is equal (within 5%) to another commonly used dose quantity, the kerma dose 
(IcRU 2005). In this thesis, the guidelines given by the International atomic 
energy agency (IAEA) and International commission on radiation units and 
measurements (IcRU) for assessing patient dose in diagnostic radiology are 
mainly used (IAEA 2007, IcRU 2005). the absorbed dose D is used as the primary 
dose quantity (Equation 1). 
(1)
where εd  is the mean energy imparted to matter of mass m (IAEA 2007). the 
special unit of absorbed dose is gray (gy). Patient dose quantities and standard 
calculation methods have been thoroughly defined earlier (AAPM 2008, IAEA 
2007, IcRU 2005, StUK 2004, Faulkner et al. 1999). the methods used in this 
thesis are introduced below.
4.2 The examination data
Studies I–III and V were based on the patient examination data collected in 
1–24 hospitals. In study I, body ct examination data of 36 trauma patients from 
an emergency hospital were recorded by a questionnaire. In study II, the data 
consisted of published material collected previously by StUK (Servomaa et al. 
2003, Parviainen et al. 2003), and new measurements were done in a central 
hospital and in a central health clinic. total number of paediatric chest patients 
was 732. In study III, the members of the SENtINEL project were asked for 
all available paediatric dose data, except for ct. the data consisted of chest, 
abdominal and pelvic radiographic examinations received from 2–9 countries, 
varying between different examination and dose quantities used. In study V, a 
national paediatric patient dose survey was organized including four university 
D
d
dm
= e ,
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hospitals, 15 central hospitals and four large district hospitals. the data consisted 
of 72–1426 patients from chest, abdominal, pelvic, skull and sinus radiography 
examinations. In study IV, which was a phantom study, the patient dose and 
image quality were evaluated in dental cBct examinations by choosing imaging 
parameters recommended by the manufacturer for four cBct scanners and two 
MSct scanners.
4.3 Patient dose in conventional radiography
Entrance surface dose (ESD) is the dose on the central X-ray beam axis at the 
point where the X-ray enters the patient or phantom, and it is mainly used in 
conventional radiography (IAEA 2007, IcRU 2005, StUK 2004). Dose-area 
product (DAP) is also mainly used in conventional radiography, but especially 
in fluoroscopy, as well al dental panoramic imaging (StUK 2004, williams 
and Montgomery 2000, Faulkner et al. 1999). ESD can be measured using 
thermoluminescent (tL) dosimeters (IAEA 2007), calculated using tube output 
data and examination parameters (Equation 2), or it can be derived from DAP, 
if the field size A is known (Equation 3). conversely, using Equation 3, DAP can 
be calculated if ESD and A are known. An easy way to determine DAP is using 
a DAP-meter. Also, many new X-ray devices have a calculatory DAP-display, 
which uses image parameters for an automatic DAP determination. ESD and 
DAP were determined in studies II, III and V by using Equations 2 and 3 or, 
when available, by using DAP-meters. In studies II and III, the tube outputs 
were measured by the author, whereas in study V the tube outputs were mainly 
reported by hospitals. 
(2)
(3)
YU,f was the measured tube output depending on the tube voltage U and the 
filtration f used in imaging. Q was the product of tube current I and exposure 
time t, FcD was the focus–chamber distance used in X-ray output measurements, 
and FSD was the focus–skin distance used when imaging the patient. In study 
II, BSF (the backscattering factor) was determined individually for every patient. 
the values ranged for chest imaging between 1.33 and 1.46, depending mainly 
on the field size A at the focus skin distance, tube voltage and the filtration 
(Harrison 1983, grosswendt 1990, cranley et al. 1991). In studies III and V, the 
mean values presented by StUK were chosen (StUK 2004).
ESD Y Q
FCD
FSD
BSFU f= ⋅ ⋅




⋅,
2
ESD BSF
DAP
A
= ⋅
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4.4 Patient dose in CT
For ct, skin dose and the dose at any specific point do not have the same 
significances as for conventional radiography, and special quantities are thus 
needed. the computed tomography dose index (ctDI, Equation 4) has been 
introduced as a fundamental dose quantity for multislice ct (Shope et al. 1981, 
AAPM 1990, Ec 1999b, IcRU 2005, IAEA 2007). However, ct dose displays 
usually report volume weighted dose index (ctDIvol, Equation 5), which represents 
the weighted mean dose absorbed to the imaged volume, as required in the 
International Electrotechnical Standard (IEc 60601). the ct doses are measured 
with a 10 cm pencil ionisation chamber inserted inside a cylindrical homogeneous 
PMMA (polymethyl methacrylate) phantom that is used to attenuate the primary 
beam and to generate scattered X-rays, simulating conditions when a patient is in 
the field (IAEA 2007). the diameter of the standard adult body phantom is 32 cm, 
and that of adult head phantom 16 cm. the ct head phantom is also used for 
paediatric imaging. In ct, dose distribution inside the phantom is heterogeneous 
so that the measured dose at the phantom surface is roughly double compared 
to the central dose (body phantom) (AAPM 2008). thus, the central tissues, such 
as pancreas and kidneys, are much more vulnerable to radiation compared to 
conventional imaging in ct. the heterogeneity is reckoned with by measuring 
the dose in the centre and periphery positions of the phantom (ctDIvol, Equation 
5) and calculating the weighted dose value, which matches better with the real 
radiation distribution in the patient compared to the use of central or surface 
values only. Also, ctDIvol takes into account any gaps or overlaps between the 
X-ray beams from consecutive rotations of the X-ray source in axial and helical 
scan modes. Analogous to the DAP and ESD, the weighted dose-length product 
DLPw, which can be calculated by multiplying ctDIvol with the total scan length L, 
is a better representative of the overall energy delivered by a given scan protocol, 
as the DLPw reflects the total energy absorbed (and thus the potential biological 
effect) attributable to the complete scan acquisition. thus, an abdomen-only ct 
exam might have the same ctDIvol as an abdominal/pelvic ct exam, but the 
latter exam would have a greater DLPw, proportional to the greater z-extent of 
the scan volume (AAPM 2008). ctDIvol can be considered to be a technical dose 
quantity, whereas DLP is more practical in patient dosimetry.
(4)
(5)
CTDI
nT
D z dz
cm
cm
100 5
51=
−∫ ( )
CTDI
nT
l
CTDI CTDI
vol
c p= ⋅
+100 1002
3
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Subscript 100 (in Equation 4) refers to the length of the pencil ionisation chamber 
(10 cm) typically used for ct dosimetry, n is the number of simultaneously 
imaged slices, T is the collimated slice thickness, and l is the table increment 
per axial scan (or helical rotation). Subscripts c, p correspond to the central and 
periphery measurement sites used for the weighted ctDI value in the standard 
ct dosimetry phantom. In study I, the console display values CTDIvol were 
compared to the CTDI100,air based method, where additional scanner specific 
corrections introduced by Brix et al. (2003, 2004) were used in the modified 
version of ct-Expo v 1.4.2 programme using patient specific scan parameters 
as a data input (Stamm and Nagel 2004, Study I). 
As the current dosimetry protocol of the AAPM (2008) uses only one 
standardized acrylic phantom representing the body of the adult patient, the 
different sizes and compositions of the patients are not reckoned with exactly. 
Individual patient dose can be estimated if the patient geometry and organ 
density are taken into account. this was done in study I by producing a correction 
factor (reff ) for standard phantom thicknesses (Equation 6) and a dose scaling 
coefficient Cd,exam (Equation 7, Huda et al. 2004, Nickoloff et al. 2003, ware et al. 
1999, Study I).
(6)
(7)
In Equation 6, the mean cross-section areas (As) and mean ct numbers in 
Hounsfield units of the region scanned (HUs) were determined for each patient. 
HUp was the ct number of the phantom used. In Equation 7, A was the linear 
coefficient for the ctDI100, µ the effective linear attenuation coefficient of the 
acrylic phantom and rref the reference phantom radius (16 cm for body region). 
the subscripts c and p (in A and µ) referred to centre and peripheral locations 
whereas the subscript exam (in Cd and rref) denoted the examined patient.
4.5 Patient dose in dental CBCT
In dental cone beam ct (cBct) examinations, patient doses have been 
determined using DAP-meters, tLDs and ct dose indexes (Lofthag-Hansen et 
al. 2008, Suomalainen et al. 2008, Ludlow and Ivanovic 2008, Ludlow et al. 2006, 
Helmrot and Alm carlsson 2005, cohnen et al. 2002). the DAP based dosimetry 
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concept takes into account the total area irradiated, but represents only the 
surface dose.  ctDIvol takes radiation distribution inside the patient roughly 
into account, whereas tLD measurements in the patient equivalent phantom 
enable the measurement of the radiation distribution more accurately, as well as 
the determination of the absorbed tissue doses. when the field of view (FOV) is 
small, the ctDI concept have been found to be erroneous, and the determination 
of the effective dose with DAP conversion factors have been found inaccurate 
(Lofthag-Hansen et al. 2008). Also, when the tube rotation is not full 360o, which 
may be the case in dental cBct applications (Ludlow et al. 2008), the ctDIp 
values diverge. In study IV, thermoluminescent dosimeters (tLDs) were used for 
measuring the central axis dose inside the FOV and for determining the absorbed 
tissue doses in dental cBct and MSct examinations. Lithium borate (Li2B4O7) 
tLDs and the Rados Dosacus RE-1/IR-1 tLD-reader/irradiator system (Rados 
technology, turku, Finland) were used for the measurements. A Sr-90 calibration 
source was used to correct the sensitivity fluctuations of individual dosimeters. 
the central axis doses were measured at the purpose-built image quality insert 
phantom, which was placed inside of the RSVP phantom (RSVP - Radiosurgery 
Verification Phantom, the Phantom Laboratory, Salem, NY, USA), providing an 
attenuation and scatter environment that resembled the human head.
4.6 Equivalent dose (HT ) and effective dose (E )
the probability of stochastic radiation effects has been found to depend on the 
magnitude of the absorbed dose, on the type and energy depositing the dose and 
on the tissue or organ irradiated (IcRP 1977, IcRP 1991, IcRP 2008, IcRU 
2005). the equivalent dose (HT) and effective dose (E) are defined as protection 
quantities, and they are used to specify exposure limits to ensure that the 
occurrence of stochastic health effects is kept below unacceptable levels, and 
that tissue reactions are avoided (Equation 8, IcRP 2008). 
(8)
wT is the tissue weighting factor for tissue or organ T, wR the radiation weighting 
factor for radiation of type R, and DT,R is the absorbed dose to the tissue. In clinical 
radiology, the wR  is 1 for the used X-ray radiation, hence the absorbed tissue dose 
(gy) equals numerically the equivalent dose (Sv). the current tissue weighting 
factors wT and their development from IcRP 1977 are presented in table 1. 
Effective dose (E) is intended to uniform the equivalent tissue doses to the whole 
body, which would have a similar risk of summarised health detriment to the 
exposure received by a reference person. It takes into account the probabilities 
E w H w w DT T
T
T
T
R T R
R
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of radiation-induced cancer, a function of life lost, lethality, loss of quality of life, 
severe hereditary effects, and it is based on the detriment for a population of all 
ages and data averaged for the both sexes. E does not relate directly to the relative 
cancer risk of an individual, as there are known differences based on age and sex. 
For individual risk assessments the equivalent tissue dose should be used as a 
primary dose quantity (IcRP 2008). In medical practice, the use of E should be 
restricted to comparing the different health detriment to a reference patient for 
different types of medical examinations (IcRP 2008, Martin 2007).
Table I. The development of tissue weighting factors wT for the effective dose determination 
(ICRP 2008).
Tissue Tissue weighting factor
ICRP 1977 ICRP 1991 ICRP 2008
Bone surfaces 0.03 0.01 0.01
Bladder - 0.05 0.04
Brain - - 0.01
Breast 0.15 0.05 0.12
Colon - 0.12 0.12
Gonads 0.25 0.20 0.08
Liver - 0.05 0.04
Lungs 0.12 0.12 0.12
Oesophagus - 0.05 0.04
Red bone marrow 0.12 0.12 0.12
Salivary glands - - 0.01
Skin - 0.01 0.01
Stomach - 0.12 0.12
Thyroid 0.03 0.05 0.04
Remainder 0.30 0.05 0.12
Total*) 1.00 1.00 1.00
*)  The list of the remainder tissues and different calculation methods for assessing 
the Dremainder are presented in ICRP 2008 (current method), ICRP 1991 (ICRP 1994 
and 1996b for a revised method to the calculation of the Dremainder), and ICRP 1977.
In practice, it is not pragmatic to conduct in vivo measurements of organ doses. 
Instead, DT can be measured using appropriate physical models of human body 
that can be loaded with dosimeters, or organ doses can be determined using 
computer programmes that simulate radiation transport inside the mathematical 
or voxel phantom. As a coarse estimation of the effective dose, there are also 
Monte carlo based conversion coefficients available for X-ray radiography and 
ct.
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4.6.1 Effective dose by Monte Carlo simulations 
in conventional radiography
the Monte carlo simulations have been found feasible for many applications in 
radiation physics (Smans et al. 2008, Andreo 1991). For patient dose calculations, 
the Monte carlo method is used to determine the energy deposition of X-ray 
photons by creating a trajectory of virtual radiation particles by simulating 
random interactions between the particles and the medium (IcRU 2005, Lampinen 
2000). In study V, the absorbed tissue doses and effective doses were determined 
in conventional paediatric radiology using the PcXMc 1.5 (StUK, Helsinki, 
Finland) – Monte carlo simulation programme (tapiovaara et al. 1997, Servomaa 
and tapiovaara 1998). PcXMc 1.5 was based on mathematical anthropomorphic 
phantom model by cristy (1980). the present software version PcXMc 2.0 is based 
on the updated phantom model by cristy and Eckermann (1987) with further 
modifications in order to fulfil the new IcRP (2008) requirements (tapiovaara 
and Siiskonen 2008). Focus-to-skin distance (FSD), field size and alignment 
determined the shape, position and orientation of the beam in the programme. the 
beam positioning was done using a graphical interface of the programme and the 
national and European guidelines for paediatric imaging (StUK 2008, Ec 1996). 
An Excel-macro script was written to assist an automated input and output of 
the examination data between the PcXMc 1.5 and tabulation including the tube 
voltage and filtration that enabled individual patient dose determinations to be 
done. For each examination, the closest age-specific phantom model was chosen 
and the size of the phantom model was further adjusted according to patient’s 
weight and height. ESD was the primary input dose indicator and PcXMc 1.5 
reported distribution of the organ doses and the corresponding effective dose. 
4.6.2 Effective dose by DLP and CTDI conversion coefficients in CT
In study I, scanner kCT and scan region fmean,st specific conversion coefficient based 
on the ctDI value were used for the effective dose determinations (Brix et al. 
2003, Shrimpton et al. 1991). coarse coefficients based on the DLP provided by 
the Ec (1999b) were also used as a comparison. conversion factors for ct are 
discussed in detail by Huda et al. (2008).
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Table II. Region specific (fmean,st) and coarse (EDLP) conversion factors used for the effective 
dose determinations. The region specific conversion factors determined for a standard 
CT scanner were used, with the scanner specific conversion kCT (0.80 for GE lightspeed 
Qx/i) to the measured CTDIair value as specified in study I. EDLP was used straight to the 
DLPw value (Brix et al. 2003, EC 1999b).
Effective dose 
conversion factor 
(mSv/mGycm)
Chest Abdomen Pelvis
fmean,st (male/female) 0.0068/0.0088 0.0072/0.0104 0.0062/0.0112
EDLP 0.017 0.015 0.019
4.6.3 Effective dose by tissue dose measurements with TLDs in CBCT
Physical dosimetry phantoms are designed to simulate the way in which the 
patient absorbs and scatters ionising radiation. In study IV, the anthropomorphic 
RANDO (Radiation Analogue Dosimetry system, Nuclear Associates, Hicksville, 
NY, USA) head phantom was used for tissue dose measurements with tLDs 
in dental cBct examinations. the phantom was designed to match the tissue 
structure and attenuation environment of the human head, including bone, soft 
tissue and airways. the phantom has been designed for radiotherapy purposes, 
but the differences in massabsorbtion (μab/ρ) coefficient for tissue equivalent 
materials allow the use of the RANDO in diagnostic radiology with an uncertainty 
less than 15%, depending on the anatomical sites (Shrimpton et al. 1981). the 
tLD chips were located at 26 phantom sites based on the method presented by 
Ludlow et al. (2006) to measure the absorbed dose to the tissues contributing to 
the effective dose. the absorbed dose to the eye lens was also measured in view 
of the known risk of deterministic detriments. 
4.7 Diagnostic reference levels in paediatric radiology
Patient’s size is an important factor in the level of dose received from X-ray 
examinations and as the variation of size is highest amongst children, the use of 
a single reference size (as suggested in Ec 1996) may be impractical. A common 
way to report paediatric patient doses is to divide children into age groups (e.g. 
Azevedo et al. 2006, gogos et al. 2003, Schultz et al. 1999). that, however, does 
not comprehensively solve the problem, because children within the same age 
group can still be of very different sizes (Hart et al. 2000b). In study II, patient 
dose in paediatric chest radiography examinations was evaluated comparing the 
standard deviations and the correlations between patient dose and the chosen 
size quantity. Patient thicknesses were measured at the central X-ray beam axis 
using a ruler, calculated from focus-skin distance and focus-detector distance 
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data, or measured from the X-ray image when both AP- and PA- projections were 
taken. the method presented by National Radiation Protection Board (NRPB), 
where normalization factors were established to normalize the doses of real 
patients to represent the doses of five standard-sized patients for whom the DRLs 
could be specified, was assessed, as well (Hart et al. 2000a,b). the third quartile 
(or 75%) values of patient doses were used to define DRL as suggested by the 
European commission (1999a). In order to set the national DRLs, there should 
be patient data collected from at least 20 national hospitals and the collection 
should include the most frequent examinations (wall 2004). In order to fulfil 
those requirements, a national paediatric patient dose survey was established 
(Study V). An approach for revising paediatric DRLs on the European level (Ec 
1996) was done in Study III by collecting paediatric dose data that were available 
among the SENtINEL partners.
4.8 Image quality
Image quality was assessed in study IV using the contrast-to-noise ratio (cNR) 
and modulation transfer function (MtF). the cNR was evaluated using regions 
of interest (ROI) of teflon and Perspex in the image quality insert phantom 
(Equation 9). the mean intensity value inside the ROIs was considered to be 
the signal and the noise was the arithmetic mean of the standard deviations in 
both ROIs.
(9)
the MtF was estimated also using the cylindrical teflon region of the image 
quality phantom insert. Analysis was performed using a self-written Matlab (the 
Mathworks Inc., Natick, MA, USA) programme. the method to determine the 
MtF resembled the method presented by Li et al. (2007). MtF was calculated 
as the spatial frequency for which the MtF amounted to 10% of its maximum 
value.
CNR
CNR CNR
Noise
Teflon Perspex=
−
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5 Results
5.1 Size and gender depended patient doses in CT
the doses of trauma ct patients were studied in study I. Analyzing the cross-
section areas and HU values, it was possible to determine a correction factor reff, 
which was used to correct the standard patient doses to represent individual 
differences. HU values were not dependent on patient weight whereas cross-
sectional areas increased linearly in both thoracic and abdominal regions. In 
figure 4, the effective radius correction factor reff is presented as a function of 
patient weight. reff correlated linearly with patient weight (p<0.001) in both scan 
regions. the size of the standard phantom (r = 16 cm) corresponded to the patient 
weight of 116 kg. Only one of the 36 patients was bigger than that.
Figure 4. Effective radius of the standard dosimetric phantom as a function of patient 
weight for correction of the standard CT dose determination protocol. Effective radius 
was determined for 36 trauma CT patients by the evaluation of the mean CT numbers 
and cross section areas of the imaged slices in full body scan (Study I). 
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Patient doses, ctDIvol , were determined using console display values, calculated 
based on the imaging parameters, and by using correction factor reff for both 
values. when applying correction for standard doses, ctDIvol were 35% and 9% 
higher than standard doses in chest and abdomen, respectively. the calculated 
ctDIvol values were 8% higher than console display values. the effective doses 
(IcRP 1991) were determined accordingly, using scanner specific corrections 
and coarse ImPAct/EU correction factors. the determined patient doses are 
presented in table III. the difference between reff corrected whole body effective 
doses of females and males is presented in Figure 5.
Table III. The mean values of dose quantities determined with different dosimetric 
methods: calculation from imaging parameters (Calc), reff -corrected calculation from 
imaging parameters (Calc-corr), console display values (Cons), reff  -corrected console 
display values (Cons-corr) and coarse correction coefficients (Coef) (Study I).
 Calc Calc-corr Cons Cons-corr Coef
Thorax      
CTDIvol (mGy) 15.2 20.4 14.1 18.9  
DLPw (mGy·cm) 431 577 398 535  
E (mSv) 6.5 8.7 6.0 8.1 6.8
Abdomen      
CTDIvol (mGy) 18.5 20.1 17.1 18.6  
DLPw (mGy·cm) 893 960 827 892  
E (mSv) 14.8 16.4 13.7 15.2 12.4
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Figure 5. Effective patient doses calculated from individual scan parameters with the 
effective radius correction to women and men. Corrected effective dose to women was 
on average 66% higher compared to men; without correction, the difference was 29% 
(Study I)
5.2 Patient dose in dental cone beam CT 
compared to multi slice CT
the absorbed dose in dental cBct was measured in two phantoms. the RSVP 
phantom provided accurate location of the tLDs on the central axis of the radiation 
beam with real scattering environment. the measured central axis doses could be 
compared directly with the image quality, which was measured in the same site 
of the image quality insert phantom (Study IV). the tissue dose measurements 
for the effective dose determinations were performed in the RANDO phantom. 
the absorbed central axis doses varied from 1 to 19 mgy for cBct scanners, 
and from 24 to 33 mgy for MSct scanners when standard imaging protocols 
were used. One cBct scanner provided 2–5 times higher central axis dose than 
other cBct scanners, while for image quality the differences were smaller 
(2.8–1.3 for contrast to noise ratio and 0.8–1.6 for modulation transfer function 
(10% value)).
the measured tissue doses in RANDO phantom corresponded to the central 
axis doses measurements by showing low values for three cBct scanners, high 
values for two MSct scanners and intermediate values for one cBct scanner 
between them. the highest tissue doses were detected for salivary glands. the 
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effective doses were 1.3–53 times higher for the MSct scanners compared to 
the cBct scanners. the highest determined effective dose was 742 µSv, when 
calculation was performed using IcRP 1991 – tissue weighting factors. Using 
the new weighting factors, the determined effective doses were 1.9–2.6 times 
higher. the measured central axis doses with standard imaging protocols (Study 
IV) and the corresponding effective doses for four cBct scanners and two MSct 
scanners are presented in Figure 6. 
Figure 6. The results of the TLD measurements of four CBCT devices compared to two 
MSCT devices. The central axis dose is the absorbed dose measured at the central axis 
of the imaged region. Effective doses were determined using both ICRP 1991 and ICRP 
2008 tissue weighting factors with standard imaging protocols (Study IV).  
5.3 Paediatric patient doses
In study II, different methods for setting paediatric reference levels in conventional 
chest X-ray imaging were evaluated. In order to calculate the statistical patient 
dose values, the patients were divided into five groups. the method presented 
by the NRPB (UK) for determining the DRLs produced 12–40 percent additional 
uncertainty and was not found feasible for Finnish practice. the chest doses 
correlated exponentially with patient thickness in LAt (r2 = 0.99) and AP (or 
PA) projections (0.86 < r2 ≤ 0.90). Diagnostic reference levels for paediatric chest 
imaging were given by StUK as functions of patient projection thicknesses 
(StUK 2006b). An example of applying the DRL is presented in Figure 7.
In both patient dose surveys (Studies III and V), paediatric dose data was 
collected from abdominal, pelvic and chest examinations. In addition, skull and 
sinus radiography doses were collected in the Finnish survey. In the Finnish 
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survey, the calculated mean values in chest examinations ranged between 
3–180 µgy for ESD (AP or PA projection), and between 3–54 mgycm2 for DAP, 
depending on the patient age group. these values were the lowest when compared 
to the European multi centre study, and thus much lower than the proposed new 
European DRLs, which ranged between 131–455 µgy (ESD) and 88–395 mgycm2 
(DAP) (Study III). In pelvic and abdominal examinations, the current European 
DRLs (Ec 1996) were 5 and 9 times higher for newborns than corresponding mean 
values in the Finnish dose survey. In the age group of 5 years, the factors were 2 
and 4. However, when compared to the new European survey, the Finnish doses 
in pelvic and abdominal examinations were similar or only slightly lower than 
the others. the data in both pelvic and abdominal examinations were lacking, so 
the new DRLs could not be proposed. In Finland, new DRLs were given for sinus 
examinations (2 mgy, 250 mgycm2) (StUK 2006b). the preliminary European 
DRLs were proposed for chest radiography (Study III).
Figure 7. An example of comparing patient doses at a hospital with the DRL curve (solid 
line). Manually inserted patient doses are presented as solid circles, and the curve fitted 
to the patient dose data is presented as a dotted line. As there are more individual patient 
doses above the DRL curve, and the curve fit is above the DRL curve, the DRL is found 
to have been exceeded. The method was based on the Study II and the data for setting 
the DRL was based on the Study V. In chest radiography, paediatric DRLs were given 
by STUK in 2006 (STUK 2006b).
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Based on the Finnish paediatric dose survey, the organ and effective patient 
doses were determined for skull, sinus, chest and abdominal radiography (Study 
V). In skull and sinus examinations the largest organ doses were calculated for 
skeleton and brain (60 μgy–300 μgy), whereas active bone marrow, thyroid, 
skin and muscles contributed the rest of the organ doses. the highest organ 
doses in abdominal examinations were calculated for liver (2010 μgy), upper 
large intestine (1466 μgy) and gall bladder (1433 μgy). In chest examinations, 
the highest organ doses were for lungs (166 μgy) and breast (169 μgy). All 
organ doses that contributed to the effective dose are listed in study V. though 
mean ESD and DAP were higher in sinus examinations compared to chest, the 
effective doses were bigger in thoracic examinations, which corresponded to the 
amount of radiated organs sensitive to X-ray radiation. the biggest effective 
doses (IcRP 1990) were determined for abdominal examinations (18–483 μSv); 
for chest the doses ranged between 6 μSv and 48 μSv, while the sinus and skull 
doses were 6 μSv–14 μSv.
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6 Discussion
6.1 Patient dose quantities, methods and uncertainties
6.1.1 Entrance surface dose (ESD) and dose-area product (DAP)
ESD and DAP values were determined for paediatric radiography in studies II, 
III and V. In study II, different sources of error were considered for projection 
radiography, when the entrance surface dose and dose-area product were 
calculated in retrospect using tube output measurements or DAP-meters 
with calibration. the estimated uncertainty of patient dose calculations was 
19% for ESD measurements and, on average, 19% for DAP measurements. 
that corresponded to the International Electrotechnical (IEc 2000) standard, 
according to which the combined standard uncertainty of 25% should not be 
exceeded when using DAP-meters. In paediatric examinations, the accuracy 
requirement implicates that high resolution (0.1 mgy cm2) is needed for DAP. 
Using DAP-meter with low resolution (e.g. 1.0 mgy cm2) for measuring paediatric 
doses doubled the uncertainty (and exceeded the IEc standard) when compared to 
the high resolution meter (Study II). For paediatric patients, there is a tendency 
of aligning the imaging field outside of the body in order to see body outlines. 
that is not an acceptable imaging protocol (StUK 2008), and it overestimates 
the DAP value, as well. However, when a DAP meter is designed and calibrated 
for paediatric purposes, its use in patient dose measurements is reliable. the 
use of a DAP meter is convenient especially when performing the large number 
of patient dose measurements needed in patient dose surveys. Both ESD and 
DAP are practical dose quantities and their use is familiar for X-ray operators. 
ESD and DAP are the recommended quantities for diagnostic reference levels in 
X-ray imaging, in conventional dental imaging, and in fluoroscopy (DAP). ESD 
pays attention to the deterministic risk of skin detriments, which is especially the 
case in fluoroscopy (geleijns and wondergem 2005), while DAP takes beam area 
into account and corresponds better with the risk of the stochastic detriments. 
6.1.2 Computed tomography dose index (CTDI) 
and dose-length product (DLP)
In study I, the uncertainty for computed tomography dose quantities (ctDIvol, 
ctDIw, DLPw) was estimated to be 10–15%. there was also a specific uncertainty 
when considering the practical dose measurements. with the total collimated 
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beam width of 20 mm used in the standard dose measurements, the dose results 
based on the standard 100 mm pencil ionization chamber were underestimated 
(10%–40%) due to limited detection of scattered radiation (Boone 2007, Mori 
et al. 2005, Dixon 2003), but the induced error was acceptable. However, when 
newer MSct scanners with potentially wider collimated beam widths are used, 
the appropriate handling of scattered radiation requires an updated dosimetric 
method, which has already been proposed in the literature (Perisinakis et al. 
2007, Dixon 2003). the calculated ctDIvol were compared to the console-displayed 
values with an 8% concordance, which was an acceptable deviation considering 
the uncertainty of the dosimetric methods. the analysis of the cross-section areas 
and HU values for the effective radius correction factor reff was performed with 
ROI and threshold techniques in a self written Matlab programme. the linear 
dependence between reff and patient weight was mainly due to linear increase 
of cross-sectional area as a function of weight in both thoracic and abdominal 
scan regions. the coefficient in the model describing the effective radius as a 
function of patient weight agreed with the published data to a reasonable extent 
(ware et al. 1999). the diameter-corrected and standard values of ctDIvol agreed 
well for the paediatric patients since the reference phantom diameter applied 
in paediatric body scans is 16 cm. thus, the presented patient size correction 
method can be used for both adult and paediatric dose evaluation purposes. the 
relative errors of the effective patient radius determinations in the abdominal 
and thoracic regions were 3.7% and 3.5%, respectively. Analogous to the ESD 
and DAP in conventional imaging, ctDI and DLP are used as DRL quantities, 
and they have a wide range of usage in quality assurance and in optimisation 
process of ct protocols.
6.1.3 Thermoluminescent dosimeter (TLD) measurements
In study IV, tLDs were used for tissue dose measurements. the energy dependence 
of the tLD output was approximately 15% from 50 keV to 1 MeV (IcRU 2005) 
and the standard deviation of corrected tLD readings was 4%, when calibrated 
with a Sr-90 calibration source (Study IV).  the expanded uncertainty (coverage 
factor of 2) was estimated to be 25% when small radiation doses were measured 
with Li2B4O7 tL dosimeters (IcRU 2005, Zoetelief 2000).  there are many 
factors influencing the tLD measurements and it is not a simple matter to give 
a specific figure for the resultant uncertainty (IAEA 2007). In study IV, tissue 
dose measurements were carried out inside the RANDO and RSVP phantoms, 
which caused uncertainty in the results as the tLD output is dependent also on 
the radiation geometry (Zoetelief 2000). However, the determined effective doses 
in study IV corresponded to the values published earlier for Accuitomo 3D cBct 
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and gE 4-slice MSct scanners (Study IV). Determining the tissue doses with 
tLDs was time-consuming and laborious when compared to the computational 
Monte carlo methods, or using pre-evaluated conversion factors. However, 
for dental ct (or cBct) imaging such conversion factors have been limitedly 
introduced (Lofthag-Hansen et al. 2008). Different conversion factors should 
be yielded for different dental regions and radiographic techniques taking new 
tissue weighting factors for granted.
6.1.4 Effective dose
Effective patient doses were determined in studies I, IV and V. E is not a 
measurable dose quantity. Instead it is derived by computation, so models and 
simulations are required in order to estimate the doses to individual tissues. 
Both mathematical and anthropomorphic phantoms have differences in the 
positions and sizes of the tissues, uncertainties in tissue properties, composition 
and radiation attenuation. IcRP now recommends voxel phantoms to be used for 
effective dose simulations (IcRP 2008). However, Smans et al. (2008) compared 
computational and voxel phantom models for paediatric purposes, and found good 
agreement between the two models. the differences were due to differences in 
phantoms and in equivalent fashion the alignment of the X-ray field. Also, the 
PcXMc version 1.5 has been evaluated against other simulation programmes 
with a reasonable agreement (Smans et al. 2008, Helmrot et al. 2007, Schultz et 
al. 2003, Schmidt et al. 2000, tapiovaara et al. 1997). Random errors arise from 
differences between the phantom modelled and the reference patient. Uncertainty 
arises both when conversion factors are used and when tissue doses are measured 
e.g. with tLDs. As the weighting factors for effective dose determination are 
based on the A-bomb data with whole body irradiation, the evaluation and 
interpretation of effective dose is problematic when organs and tissues receive 
only partial exposure, or a very heterogeneous exposure, which especially is 
the case with diagnostic imaging (IcRP 2008). Martin (2007) has detailed the 
uncertainty in medical effective dose determinations. the uncertainty in E as a 
relative value for different types of medical exposure was ±40% for an 80–90% 
confidence limit. the revision of the weighting factors (IcRP 1991, 2008) has 
changed E by less than 20% for the majority of exposures of the trunk (Martin 
2007). However, larger changes were involved for some examinations involving 
fewer organs, such as those in dental radiology (Study IV). 
the effective dose is derived for workers and the general population, for 
which the age distribution can differ from the overall age distribution for the 
patients undergoing medical procedures using ionising radiation (IcRP 2008). 
Also, the risk for different age groups for uniform whole-body examinations varies 
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by a factor of 4–5 between children and the elderly (Pierce 2002). thus, assessing 
the individual radiation risks for medical diagnosis when ionising radiation is 
used should be evaluated using mean absorbed doses for the individual tissues 
at risk, and combining these with the latest available age-, sex- and organ-
specific risk coefficients for radiation-induced stochastic effects (Martin 2007). 
Effective dose should not be used for individual risk assessments. In diagnostic 
imaging, effective dose can be used for comparing the relative doses from different 
diagnostic procedures, and for comparing the use of similar technologies and 
procedures in different hospitals and countries. In addition, effective dose can 
be used for comparing the use of different technologies for the same medical 
examination, provided that the reference patient or patient populations are 
similar with regard to age and sex (Martin 2007).
In section 2, studies and organisations endorsing the linear no-threshold 
theory were covered. when compared to higher doses, the risks of low doses of 
radiation are likely to be lower, thus progressively larger epidemiological studies 
are required to quantify the risk to a useful degree of precision. For example, 
the study of nuclear workers had to be expanded to 400 000 cohort members 
until the influence of low dose radiation could be separated from background 
cancer incidence probability (cardis et al. 2005, 2007). while the LNt theory 
has been found difficult to be proved with low doses, there has been an ongoing 
debate on other dose response models, led by the French National Academies 
of Science and of Medicine (Feinendegen et al. 2008, Mossman 2008, Leonard 
2008, tubiana et al. 2006 and 2007, Breckov 2006, etc.). According to them, the 
efficacy of the two guardians of the genome, DNA repair and programmed cell 
death, varies with dose and dose rate, and the use of LNt for assessing the 
risks of doses below 20 mSv is unjustified and should be discouraged (tubiana 
et al. 2006). Also, interesting results have been presented based on the data 
of 10 000 cohort members of a taiwanese radiation incident, which indicated 
that a dose rate of the order of 50 mSv per year would greatly reduce cancer 
mortality (chen et al. 2004). the debate on low dose radiation risks will not be 
solved in the near future, and one has to rely on his/hers own ability to justify 
the profits and detriments of a medical radiation procedures. Although there are 
uncertainties in the quantity E, it still is the only general dose quantity which 
can link physically measurable dose quantities and risk of health detriment. In 
particular, E is practical during optimisation in radiology when comparing doses 
from different radiological techniques. Patients or referring physicians repeatedly 
ask for this information, not ESD, DAP, cDtI or DLP.
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6.1.5 Patient data
Patient doses were determined in studies I–III and V based on the real patient 
data using actual imaging parameters for the individual patient dose detection, 
which enabled estimation of the average dose for a chosen population. choosing 
the patient samples instead of phantoms, enabled to detect dose variations 
which are common in practice due to differences in patient size, variations in 
technique or skill between the individuals performing the examination, and 
differences in exposure factors that were locally selected. Such information could 
only be obtained by measuring the patient dose for a sample of patients, instead 
of phantom measurements in standard environment. typically, in patient dose 
studies, it is important to select patients according to their anatomical parameters, 
such as weight and age. In this thesis it was intended to compare doses of different 
sized patients, so the large variation of patient sizes in the samples was desirable. 
However, depending on the study, the size of the sample for reliable statistical 
analysis varied. In study I, which was a methodological dosimetric study, the 
sample of 36 patients collected in one hospital was considered adequate, whereas 
sample sizes were as much as 20–50 times bigger in studies II–III and V, where 
Finnish or European dose levels were established. Large patient dose surveys 
may be problematic, since exact recording of the examination parameters is 
crucial. In a hospital, patient dose registration is usually done in addition to daily 
routine and may cause extra workload. thus it is important to provide personnel 
with well-defined instructions and with simple questionnaires to make patient 
data collection as easy as possible. A possibility for online reporting and good 
availability for further assistance enables productive collaboration between the 
parties involved. when patient dose surveys are initiated, hospitals are often 
reminded of the legislative basis of patient dosimetry. However, the most efficient 
way to execute such surveys would be real co-operation by encouraging hospitals 
to participate in optimisation and in searching of a good practice in X-ray imaging. 
Furthermore, hospitals should receive direct feedback for their teamwork, and 
any results of the survey should be presented straight to hospitals.
6.2 Patient doses
6.2.1 Computed tomography and dental cone beam CT
trauma patients were chosen for the computed tomography study (Study I) 
because of the widest scan area and thus potentially high patient doses. the 
determined doses ranged from 6 mSv to 35 mSv with a mean value of 20 mSv, 
proving that full body ct patients represent the highest dose group in diagnostic 
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radiology. the determined doses were slightly lower compared to other trauma ct 
studies (winslow et al. 2008, tien et al. 2007). the doses were in the proximity of 
statistically significant evidence of increased cancer risk (chapter 2), and thus 
no extrapolation to low doses of LNt-model is needed when the radiation risk 
is considered (Hall 2008). It has been concluded that the use of ct is associated 
with a non-negligible lifetime attributable risk of cancer (Einstein et al. 2007). 
In USA, it is estimated that one third of ct examinations may have been done 
with inappropriate referrals (Brenner and Hall 2007). However, in an emergency 
room with multiply injured patients, ct has been considered critical to patient 
management, thus trauma ct is justified in most of the cases (Boland 2008). the 
determined trauma ct doses depended strongly on the patient size and gender. 
Differences in scan lengths led to differences in DLP values, as anticipated for 
different sized patients. However, the slice-specific doses independent of the scan 
length (ctDIvol) within the same anatomical regions presented an inappropriate 
trend according to the patient size. the diameter-corrected mean effective dose 
from the whole examination of women was 65% higher than for men. that was 
due to two interrelated reasons: a smaller diameter and higher fmean values of 
women in the trunk area compared to men. thus, the need for optimisation of 
scan parameters for smaller patients is clearly emphasised, because this patient 
group includes mainly women with higher resultant exposures. the observed 
difference suggests that the use of standard dose quantities alone does not provide 
an adequate estimate of the patient doses that are delivered in ct. the use of 
patient size in dose estimation is therefore recommended in order to provide 
realistic dose quantities, to be used in referral evaluation, and to be registered 
for possible radiation risk calculations. this concerns especially children, women 
and smaller patients. In general, as ct contributes half of the diagnostic X-ray 
population dose and can be detrimental for individual patients, more concern 
should be drawn to the radiation protection of the ct.
Standard imaging methods in dental radiology include panoramic and 
intraoral radiographs, as well as other conventional tomographs and cephalograms. 
the use of ct in dentistry is limited, but the number of dental cBct scanners 
is growing quickly. In standard dental imaging, patient doses are low (6 µSv 
for a panoramic image), which is 40 times less than the highest effective doses 
of the cBct scanners examined (Study IV). when a cBct examination is 
planned, it should be carefully considered whether the additional information 
contributes to the diagnosis and what its impact on the treatment of the patient 
is. Although cBct imaging is a promising and already widely used diagnostic 
tool, definite recommendations on its clinical use are not available at this time. 
Large dose differences between cBct scanners were detected without explaining 
the difference in image quality, which indicated the lack of optimisation. Further 
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studies are needed to evaluate low-dose MSct and cBct examinations, both of 
which are rapidly developing techniques in modern radiology. 
6.2.2 Paediatric radiography
the most of the collected paediatric data in studies II, III and V consisted of chest 
X-ray examinations. that was logical as chest radiography is the most frequent 
examination performed for children; in Finland about 30% of all paediatric X-ray 
examinations are chest examinations (Servomaa et al. 1997). Patient dose in a 
single chest X-ray is relatively low, ranging from 6 μSv to 48 μSv (Study V), but 
the contribution to the total collective paediatric radiation exposure is significant 
due to the high imaging frequency compared to the ct. contribution of different 
organs to the effective dose in different paediatric X-ray examinations was 
discussed in study V. In all examinations, there were large variations in imaging 
protocols and patient doses; thus emphasising the need for harmonisation. In 
sinus examinations, increasing focus to skin distance could have decreased the 
highest exposures by 30–60%. the effective doses in abdominal radiography were 
the highest of all. However, there was potential to improve optimisation by proper 
use of automatic exposure control and ensuring recommended imaging distances, 
especially in standing positions. In chest examinations, optimised projection (PA) 
should be utilized generally. the optimisation of pelvic radiography could have 
been improved by ensuring adequate tube voltage, imaging distance and utilizing 
the cu filtration when available. In general, aligning the beam outside of the 
body overestimated the effective dose when DAP was used as the dosimetric 
source data.
6.2.3 Diagnostic reference levels
compared to adults, the number of paediatric X-ray examinations is small. 
therefore, it is difficult to collect enough patient data (at least 10 patients, wall 
2004) if the DRLs are given separately for each size group. A more practical 
method was presented in study II, where the paediatric chest DRLs were given 
as a function of patient thickness (StUK 2006b). when paediatric DRLs are 
presented as a curve, hospitals can compare their patient doses directly against 
the graph, and the need for a large number of patients is significantly reduced. 
According to an enquiry to university and central hospitals, the preliminary 
experiences in the application of the DRL curve were promising (Study II). As 
expected, using the DRL curve had simplified the procedure and reduced the 
workload when comparing patient doses with the DRLs. Of even more importance 
to the hospitals, the graphical illustration of patient doses had provided an 
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overview of the whole scale of the patient doses, which had then helped to 
choose an optimal imaging technique depending on patient size. In Finland, the 
paediatric DRLs were also given for sinus radiography (StUK 2006b). For sinus 
radiography, a single DRL was given, as the dependence of doses and patient size 
was considered small enough. Sinus radiography is not an acceptable imaging 
technique for children under the age of seven (StUK 2008). 
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7 Conclusions
In all studies included in this thesis, large variations in radiation exposure for a 
specific type of X-ray examination were discovered. there were variations between 
different hospitals and examination rooms, between different sized patients, and 
between imaging techniques; thus emphasising the need for harmonization of the 
examination protocols. A correction coefficient for ct, taking individual patient 
size into account, was created. the coefficient describing the effective radius 
as a function of patient weight agreed with the published data, and corrected 
values of ctDIvol agreed well also for the paediatric patients. the presented 
patient size correction method can be used for both adult and paediatric ct. 
Radiation absorption of children, women and smaller patients was found to be 
large compared to big patients in computed tomography examinations. Dental 
cone beam ct scanners provided adequate image quality for dentomaxillofacial 
examinations, while delivering considerably smaller effective doses to patients 
compared to the multi slice ct. Large dose differences between cBct scanners 
were detected without explaining the difference in image quality, thus indicating 
the lack of optimisation. For paediatric radiography, a graphical method was 
found ideal for setting the diagnostic reference levels in chest examinations, and 
the DRLs were given as a function of patient projection thickness. Paediatric 
DRLs were also given for sinus radiography. In Finland, paediatric patient 
doses in chest examinations were much lower, whereas in abdominal and pelvic 
radiography the doses were similar or only slightly lower, when compared to 
the European multi-national study. the detailed information about the collected 
data, exposure parameters and procedures provided tools for reducing the 
patient doses in paediatric radiography. the mean tissue doses presented for 
paediatric radiography enabled future risk assessments to be done. the calculated 
effective doses can be used for comparing different diagnostic procedures, and for 
comparing the use of similar technologies and procedures in different hospitals 
and countries. 
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